SKYE Annual Shareholders Equity
-$2.13 M
+$876.30 K+29.13%
01 December 2023
Summary:
As of January 28, 2025, SKYE annual stockholders equity is -$2.13 million, with the most recent change of +$876.30 thousand (+29.13%) on December 1, 2023. During the last 3 years, it has fallen by -$2.58 million (-572.89%). SKYE annual shareholders equity is now -136.35% below its all-time high of $5.86 million, reached on December 1, 2021.SKYE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SKYE Quarterly Shareholders Equity
$75.80 M
+$2.99 M+4.11%
01 September 2024
Summary:
As of January 28, 2025, SKYE quarterly stockholders equity is $75.80 million, with the most recent change of +$2.99 million (+4.11%) on September 1, 2024. Over the past year, it has dropped by -$3.08 million (-3.90%). SKYE quarterly shareholders equity is now -3.90% below its all-time high of $78.88 million, reached on March 1, 2024.SKYE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SKYE Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +29.1% | -3.9% |
3 y3 years | -572.9% | +2407.6% |
5 y5 years | +86.3% | +2407.6% |
SKYE Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -136.3% | +29.1% | -3.9% | +1073.2% |
5 y | 5-year | -136.3% | +29.1% | -3.9% | +1073.2% |
alltime | all time | -136.3% | +86.3% | -3.9% | +372.1% |
Skye Bioscience Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $75.80 M(+4.1%) |
June 2024 | - | $72.81 M(-7.7%) |
Mar 2024 | - | $78.88 M(-3800.3%) |
Dec 2023 | -$2.13 M(-29.1%) | -$2.13 M(-225.7%) |
Sept 2023 | - | $1.70 M(-121.8%) |
June 2023 | - | -$7.79 M(+62.9%) |
Mar 2023 | - | -$4.78 M(+58.9%) |
Dec 2022 | -$3.01 M(-151.3%) | -$3.01 M(-8.4%) |
Sept 2022 | - | -$3.29 M(+988.5%) |
June 2022 | - | -$301.80 K(-110.2%) |
Mar 2022 | - | $2.97 M(-49.3%) |
Dec 2021 | $5.86 M(+1200.8%) | $5.86 M(-29.0%) |
Sept 2021 | - | $8.26 M(+263.9%) |
June 2021 | - | $2.27 M(-8.4%) |
Mar 2021 | - | $2.48 M(+449.8%) |
Dec 2020 | $450.80 K(-17.8%) | $450.80 K(-75.7%) |
Sept 2020 | - | $1.85 M(-159.9%) |
June 2020 | - | -$3.09 M(+81.7%) |
Mar 2020 | - | -$1.70 M(-410.7%) |
Dec 2019 | $548.10 K(-103.5%) | $548.10 K(-103.3%) |
Sept 2019 | - | -$16.40 M(+40.9%) |
June 2019 | - | -$11.64 M(-58.2%) |
Mar 2019 | - | -$27.86 M(+79.0%) |
Dec 2018 | -$15.56 M | -$15.56 M(+53.2%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2018 | - | -$10.16 M(+23.2%) |
June 2018 | - | -$8.25 M(+43.3%) |
Mar 2018 | - | -$5.75 M(+619.2%) |
Dec 2017 | -$800.10 K(-44.9%) | -$800.10 K(-62.0%) |
Sept 2017 | - | -$2.11 M(+18.4%) |
June 2017 | - | -$1.78 M(+44.6%) |
Mar 2017 | - | -$1.23 M(-15.3%) |
Dec 2016 | -$1.45 M(-408.0%) | -$1.45 M(+42.4%) |
Sept 2016 | - | -$1.02 M(+298.9%) |
June 2016 | - | -$255.50 K(-74.7%) |
Mar 2016 | - | -$1.01 M(-314.5%) |
Dec 2015 | $471.00 K(-203.9%) | $471.00 K(-54.1%) |
Sept 2015 | - | $1.03 M(-219.2%) |
June 2015 | - | -$861.00 K(+154.4%) |
Mar 2015 | - | -$338.40 K(-25.4%) |
Dec 2014 | -$453.50 K(-643.8%) | -$453.50 K(-158.4%) |
Sept 2014 | - | $776.30 K(+857.2%) |
July 2014 | - | $81.10 K(+10.5%) |
Apr 2014 | - | $73.40 K(-15.6%) |
Jan 2014 | - | $87.00 K(+4.3%) |
Oct 2013 | $83.40 K(+116.1%) | $83.40 K(+28.9%) |
July 2013 | - | $64.70 K(-1.4%) |
Apr 2013 | - | $65.60 K(+69.9%) |
Oct 2012 | $38.60 K | $38.60 K |
FAQ
- What is Skye Bioscience annual stockholders equity?
- What is the all time high annual shareholders equity for Skye Bioscience?
- What is Skye Bioscience annual shareholders equity year-on-year change?
- What is Skye Bioscience quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Skye Bioscience?
- What is Skye Bioscience quarterly shareholders equity year-on-year change?
What is Skye Bioscience annual stockholders equity?
The current annual shareholders equity of SKYE is -$2.13 M
What is the all time high annual shareholders equity for Skye Bioscience?
Skye Bioscience all-time high annual stockholders equity is $5.86 M
What is Skye Bioscience annual shareholders equity year-on-year change?
Over the past year, SKYE annual stockholders equity has changed by +$876.30 K (+29.13%)
What is Skye Bioscience quarterly stockholders equity?
The current quarterly shareholders equity of SKYE is $75.80 M
What is the all time high quarterly shareholders equity for Skye Bioscience?
Skye Bioscience all-time high quarterly stockholders equity is $78.88 M
What is Skye Bioscience quarterly shareholders equity year-on-year change?
Over the past year, SKYE quarterly stockholders equity has changed by -$3.08 M (-3.90%)